Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 117

1.

Loss of expression of tropomyosin-1, a novel class II tumor suppressor that induces anoikis, in primary breast tumors.

Raval GN, Bharadwaj S, Levine EA, Willingham MC, Geary RL, Kute T, Prasad GL.

Oncogene. 2003 Sep 18;22(40):6194-203.

PMID:
13679858
2.

Suppression of the transformed phenotype of breast cancer by tropomyosin-1.

Mahadev K, Raval G, Bharadwaj S, Willingham MC, Lange EM, Vonderhaar B, Salomon D, Prasad GL.

Exp Cell Res. 2002 Sep 10;279(1):40-51.

PMID:
12213212
3.

Tropomyosins of human mammary epithelial cells: consistent defects of expression in mammary carcinoma cell lines.

Bhattacharya B, Prasad GL, Valverius EM, Salomon DS, Cooper HL.

Cancer Res. 1990 Apr 1;50(7):2105-12.

4.

N terminus is essential for tropomyosin functions: N-terminal modification disrupts stress fiber organization and abolishes anti-oncogenic effects of tropomyosin-1.

Bharadwaj S, Hitchcock-DeGregori S, Thorburn A, Prasad GL.

J Biol Chem. 2004 Apr 2;279(14):14039-48. Epub 2004 Jan 12.

5.

Cytoskeletal organization in tropomyosin-mediated reversion of ras-transformation: Evidence for Rho kinase pathway.

Shah V, Bharadwaj S, Kaibuchi K, Prasad GL.

Oncogene. 2001 Apr 19;20(17):2112-21.

6.

Suppression of neoplastic transformation and regulation of cytoskeleton by tropomyosins.

Shah V, Braverman R, Prasad GL.

Somat Cell Mol Genet. 1998 Sep;24(5):273-80.

PMID:
10696235
7.
8.

Suppression of src-induced transformed phenotype by expression of tropomyosin-1.

Prasad GL, Masuelli L, Raj MH, Harindranath N.

Oncogene. 1999 Mar 18;18(11):2027-31.

9.

Downregulation of tropomyosin-1 in squamous cell carcinoma of esophagus, the role of Ras signaling and methylation.

Zare M, Jazii FR, Soheili ZS, Moghanibashi MM.

Mol Carcinog. 2012 Oct;51(10):796-806. doi: 10.1002/mc.20847. Epub 2011 Aug 30.

PMID:
22965424
10.

Extracellular matrix metalloproteinase inducer (CD147) confers resistance of breast cancer cells to Anoikis through inhibition of Bim.

Yang JM, O'Neill P, Jin W, Foty R, Medina DJ, Xu Z, Lomas M, Arndt GM, Tang Y, Nakada M, Yan L, Hait WN.

J Biol Chem. 2006 Apr 7;281(14):9719-27. Epub 2006 Jan 27.

11.

Resensitization of breast cancer cells to anoikis by tropomyosin-1: role of Rho kinase-dependent cytoskeleton and adhesion.

Bharadwaj S, Thanawala R, Bon G, Falcioni R, Prasad GL.

Oncogene. 2005 Dec 15;24(56):8291-303.

PMID:
16170368
12.

Down-regulation of the tumor suppressor protein 14-3-3sigma is a sporadic event in cancer of the breast.

Moreira JM, Ohlsson G, Rank FE, Celis JE.

Mol Cell Proteomics. 2005 Apr;4(4):555-69. Epub 2005 Jan 11.

13.

Expression of tropomyosin isoforms in benign and malignant human breast lesions.

Franzén B, Linder S, Uryu K, Alaiya AA, Hirano T, Kato H, Auer G.

Br J Cancer. 1996 Apr;73(7):909-13.

14.

Wnt signalling in human breast cancer: expression of the putative Wnt inhibitor Dickkopf-3 (DKK3) is frequently suppressed by promoter hypermethylation in mammary tumours.

Veeck J, Bektas N, Hartmann A, Kristiansen G, Heindrichs U, Knüchel R, Dahl E.

Breast Cancer Res. 2008;10(5):R82. doi: 10.1186/bcr2151. Epub 2008 Sep 30.

15.

Expression of miR-21 and its targets (PTEN, PDCD4, TM1) in flat epithelial atypia of the breast in relation to ductal carcinoma in situ and invasive carcinoma.

Qi L, Bart J, Tan LP, Platteel I, Sluis Tv, Huitema S, Harms G, Fu L, Hollema H, Berg Av.

BMC Cancer. 2009 May 28;9:163. doi: 10.1186/1471-2407-9-163.

16.

A novel splice variant of the beta-tropomyosin (TPM2) gene in prostate cancer.

Assinder SJ, Au E, Dong Q, Winnick C.

Mol Carcinog. 2010 Jun;49(6):525-31. doi: 10.1002/mc.20626.

PMID:
20336778
17.

14-3-3 zeta down-regulates p53 in mammary epithelial cells and confers luminal filling.

Danes CG, Wyszomierski SL, Lu J, Neal CL, Yang W, Yu D.

Cancer Res. 2008 Mar 15;68(6):1760-7. doi: 10.1158/0008-5472.CAN-07-3177.

18.

Loss of the expression of the tumor suppressor gene ARHI is associated with progression of breast cancer.

Wang L, Hoque A, Luo RZ, Yuan J, Lu Z, Nishimoto A, Liu J, Sahin AA, Lippman SM, Bast RC Jr, Yu Y.

Clin Cancer Res. 2003 Sep 1;9(10 Pt 1):3660-6.

19.

Large isoform of MRJ (DNAJB6) reduces malignant activity of breast cancer.

Mitra A, Fillmore RA, Metge BJ, Rajesh M, Xi Y, King J, Ju J, Pannell L, Shevde LA, Samant RS.

Breast Cancer Res. 2008;10(2):R22. doi: 10.1186/bcr1874. Epub 2008 Mar 7.

20.

Anti-oncogenic effects of tropomyosin: isoform specificity and importance of protein coding sequences.

Braverman RH, Cooper HL, Lee HS, Prasad GL.

Oncogene. 1996 Aug 1;13(3):537-45.

PMID:
8760295
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk